Treatment of Age-Related Macular Degeneration With Anecortave Acetate
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide compassionate use of anecortave acetate sterile
suspension of 15 mg for a series of five patients as a means to control classic
neovascularization following failure of treatment with photodynamic therapy using Visudyne.